Cystic Fibrosis Twin and Sib Study

Johns Hopkins University

 
Patients
Study Information

 

The CF Twin/Sib Study team is conducting a nationwide collection of twins and siblings with CF, sponsored by the Cystic Fibrosis Foundation and the National Institutes of Health. We are obtaining a blood sample from twins, siblings, and their parents, and clinical information from the affected twins and siblings. All information collected will be kept confidential and will be used solely for CF research.

This information will be used to determine which patient symptoms may be attributed to the CF (CFTR) gene and which to other possible genes. It will also be used to study the interaction of genes and environment in CF and the effect this has on disease course.

Who is funding this study?

This study is funded by the Cystic Fibrosis Foundation (CFF) and the National Institutes of Health.  Johns Hopkins Medicine is the Coordinating Center, and over 100 CF Centers from the US, Australia, and Great Britain are participating in the recruiting efforts. For more information on the National Institues of Health or the CFF, please see our collection of CF-related links.

What do I have to do?

We ask you or your children to give a blood sample, to answer a few questions, and to have information from you or your children's medical records. This means that investigators from Johns Hopkins Medicine will be reviewing your or your children's medical information. The information will include birth history, medication use, current health status, diagnostic information, growth parameters, pulmonary function data, results of laboratory tests and chest X-rays. The duration of your involvement will include time to obtain the blood sample and to answer personal health, family health, and environmental questions and should take approximately 30 to 40 minutes.

Patients are typically enrolled in the study through their physician; however, we are able to accept direct referrals.  CF families who are interested in participating in the study are encouraged to contact us.

Why twins?

A twin study provides a powerful method of determining the contribution of genes to a disease trait. It  allows us to ask direct questions about genetic control over symptoms of CF and to search for the genes involved. Twins share both environment and genes. Identical (monozygous) twins have the same DNA from each parent and share 100% of their genes. They also share environment before and after birth. The study of identical twins provides insight into environmental effects on disease and the effects of the interaction of genes with the environment.

Like identical twins, fraternal (dizygous) twins share both the womb environment and the family environment after birth. However, they share, on average, only 50% of their genes. By comparing identical twins with fraternal twins, we can determine the contribution of genes( in addition to or interacting with the CF gene )to differences in patient outcome.

Why siblings?

Siblings share on average 50% of their genes and generally share family environment after birth. They help us to further clarify the role of genes and shared environmental factors in the severity of cystic fibrosis. Further, siblings allow us to explore age-related factors. A sib-pair study provides a powerful method of identifying genes contributing to disease. There are far fewer twin pairs with CF than there are sibling pairs, so the addition of sibling pairs enables us to look at symptoms that occur less frequently.

At the completion of the research, we will have more comprehensive knowledge of which CF symptoms are effected by genes and which are influenced more by environment (treatment, diet, etc.).  This knowledge will aid  CF Researchers and Care Providers in helping to assess risk, and develop/tailor treatments.

Why parents?

Identifying and understanding the  differences in transmission of  genes from parent to offspring enables us to isolate candidate genes that contribute to the severity of CF disease.
 
Why your participation is important
Discovering the genetic modifiers of CF will increase our understanding of the mechanisms of the disease and its symptoms. If we were able to have every sibling or twin with CF in this country participate in this study, our ability to detect genetic differences and environmental differences would be very powerful.Once those differences have been identified, we will be better able to care for people with CF.
 
What happens to my sample?

We are collecting your blood in order to create a permanent source (a bank) of DNA for genetic analysis for each individual. Creating this bank will enable us to research many possible candidate genes without having to draw more blood from patients in order to perform future tests. The blood will be used to extract DNA, the substance in your cells that contains genes, and to establish cell lines A gene is the unit of heredity which is received from each parent that determines a person's characteristics. A cell line is made from white blood cells, which are treated in a way that causes them to grow and allows researchers to create an unlimited supply of DNA on which to conduct tests. This DNA will be used solely for CF research.

This study employs a system for preserving anonymized, code-identified samples of your blood and tissues indefinitely at Johns Hopkins for use in future research for genetic variation in CF. If authorized CF researchers from sites other than Johns Hopkins ask to study factors that contribute to the variability of CF using these samples and your clinical data, they will receive samples and data that have been stripped of any information identifying you.

For more information about the collection and storage of blood samples, please continue.

Read more...
 
Participating CF centers in your area

The following institutions are active participanting Care Centers in the CF Twin Sib Study.

United States Participants

State

City

Organization Name

AL Birmingham University of Alabama at Birmingham
AZ Phoenix Phoenix Children's Hospital
CA
Los Angeles Children's Hospital of Los Angeles
Oakland Kaiser Permanente Medical Center
Orange County Children's Hospital of Orange County
Sacramento Sutter Medical Center
CT Hartford Connecticut Children's Medical Center
New Haven Yale University SOM
FL St. Petersburg All Children's Hospital
IA Iowa City University of Iowa Hospitals & Clinics
ID Boise St. Luke's CF Clinic
IL Chicago University of Chicago Hospitals
University of Chicago Children's Hospital
Children's Memorial Hospital & Northwestern University
Glenview Children's Asthma Respiratory & Exercise Specialists
IN Fort Wayne Lutheran Hospital
KS Wichita Via-Christi- St. Francis Campus
MA
Boston Tufts- New England Medical Center
Children's Hospital of Boston
Worcester University of Massachusetts Memorial Health Care
MD Baltimore Johns Hopkins Hospital
MI Lansing Michigan State University
MN Minneapolis University of Minnesota
Children's Hospitals and Clinics of Minneapolis
MO Kansas City Children's Mercy Hospital and Clinics
St. Louis Washington University School of Medicine
MS Jackson University of Mississippi Medical Center
NC Chapel Hill UNC at Chapel Hill
ND Bismarck St. Alexius Heart & Lung CF Clinic
NH Lebanon Dartmouth-Hitchcock Medical Center
Morristown Morristown Memorial Hospital
NM Albuquerque University of New Mexico, SOM
NY Albany Albany Medical College
Rochester University of Rochester Medical Center, Strong Memorial
Syracuse SUNY Upstate Medical University
OH Akron Children's Hospital Medical Center of Akron
Cincinnati Cincinatti Children's Hospital and Medical Center
Cleveland Rainbow Babies and Children's Hospital
Columbus Columbus Children's Hospital
Toledo Toledo Children's Hospital
OR Portland Kaiser Permanente
PA Philadelphia Children’s Hospital of Philadelphia
Pittsburgh
Children's Hospital of Pittsburgh
TN Memphis University of Tennessee LeBonheur Children’s Hospital
Nashville Vanderbilt University Medical Center
TX Dallas St. Paul Medical Center
Children's Medical Center of Dallas
Fort Worth Cook Children's Medical Center
Houston Texas Children's Hospital
Baylor Clinic
Tyler University of Texas at Tyler Health Center
UT Salt Lake City University of Utah Health Sciences Center
VA Portsmouth Naval Medical Center - Portsmouth
Richmond Virginia Commonwealth University
VT Burlington Fletcher Allen Health Care
WA Seattle University of Washington Medical Center
Children’s Hospital & Regional Medical Center
Spokane Providence Medical Center
WI Green Bay St. Vincent Hospital
Marshfield Marshfield Clinic
Milwaukee Children's Hospital of Wisconsin and Froedert Hospital
WV Morgantown West Virginia University


International Participants

Country

City

Institution

Australia Herston, Queensland Royal Children’s Hospital and the Prince Charles Hospital
Israel Jerusalem Hadassah Medical Center
Scotland Edinburgh Royal Hospital for Sick Children
 

Newsflash

Want to learn about new and future research studies? Click here to find out what we're up to.

Study Sponsors

Johns Hopkins Medicine and The Johns Hopkins Hospital

 

National Institutes of Health

 

Cystic Fibrosis Foundation

 

NACFMC-logo